Rahul R Aggarwal

41PUBLICATIONS

358CO-AUTHORS

Molecular targetsToxicology (incl. clinical toxicology)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (41)

Sort by Publication Date:

|Jun 01, 2026

Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study.

|May 11, 2026

Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer.

|Feb 26, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 13, 2026

Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Jan 22, 2026

Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.

Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa

|Nov 13, 2025

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Andre L De Souza, Matthew J Hadfield, Shaolei Lu

Pageof 7

Frequent Collaborators

15 joint publications

Eric Small

Felix Y Feng

David Quigley

Jonathan Chou

Alexander W Wyatt

Joshi J Alumkal

Himisha Beltran

Robert R Flavell

Meng Zhang

Martin Sjöström

Frequent Collaborators

15 joint publications

Eric Small

9 joint publications

Felix Y Feng

7 joint publications

David Quigley

7 joint publications

Jonathan Chou